How did you decide to participate in the Biomapas Academy?
When I used to walk past a pharmacy every day, I could never stop dreaming about being able to help people and develop innovative pharmaceuticals. So while studying biomedical sciences, I became interested in the drug development paths, which led me to medicinal chemistry. And one day at the university, I saw a poster about the Biomapas Academy, which could help me understand what, how, where, and when happens to pharmaceutical products during the whole journey to reach us, so I signed up for it without hesitation. Even though I am usually not a lucky person, I was selected to be one of the participants, which surprised me!
How was your experience regarding the Academy?
During the few months, I deepened my existing knowledge of drug development stages and expanded it to learn more about drug regulation and pharmacovigilance. After graduating from the Academy, I got the opportunity to try out regulatory affairs as part of Biomapas – I completed a summer internship in the Regulatory Affairs department.
How do you feel after graduating from the Academy?
I will never forget this practice in my life, not only because it fulfilled what I was looking for, but it let me realize that I want to return to this company after my graduation and put my accumulated knowledge to use. Thanks again to all Biomapas staff for their insights and advice, and I hope to see you soon.
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Regulatory Framework of Drugs in MENA: Insights
In this webinar, our experts discuss regulatory affairs of medicinal products. Two aspects that have recently gained increasing importance among the various stakeholders, namely the eCTD implementation across the region and the serialization and barcoding requirements...
How to Set Up and Manage Local Pharmacovigilance Networks for Global Compliance
Structure compliant local PV networks while maintaining centralized oversight, from regulatory obligations, partner selection, QPPV responsibilities, technology integration and outsourcing within a scalable strategy.
How medical writing supports every stage of the drug’s lifecycle
Discover how medical writing for clinical trials supports each phase of drug development with essential documentation.
Unlock the full potential of your medical writing outsourcing
When clinical timelines are tight and regulatory expectations keep shifting, outsourced medical writing becomes a competitive edge. The right medical writing CRO can help you scale document production, stay aligned with evolving compliance standards, and bring your...
Exploring Regulatory, Inspection, and Cultural PV Trends in APAC
Explore evolving APAC PV trends: cultural diversity, CBDT rules, inspections, RMPs, outsourcing, and vendor audit best practices.
How the right CRO site network partnership accelerates clinical trials
Explore how these partnerships work in practice, why Sponsors in Europe increasingly prefer them, and the regulatory push behind the shift.
MENA PV Landscape – Key Updates & Inspection Trends
Timely insights on the evolving Pharmacovigilance landscape in the MENA region.
Navigating Pharmacovigilance Requirements in LATAM
Insights into the evolving Pharmacovigilance landscape across the LATAM region.
Centralized Pharmacovigilance: Ensuring Compliance and Efficiency Across Global Markets
This article explores the benefits of centralized pharmacovigilance outsourcing and the single-provider model.
Diversity in Clinical Trials: A European Perspective on Global Progress and Strategies
Discover insights on diversity in clinical trials, regulatory compliance to inclusion, the European approach, and trial design innovations.
